New Molecules

Showing 73–84 of 107 results

• 
  API

  Patisiran

  CAS:1386913-72-9

• 
  API

  Pegcetacoplan

  CAS:2019171-69-6

  Status:R&D

  Indications:Diseases of blood and hematopoietic organs
• 
  ADC

  Pirarubicin

• 
  API

  Plecanatide

  CAS:467426-54-6
  Status:Validation Completed, DMF (2025)
  Indications:Diseases of the digestive system

• 
  ADC

  Polymyxin B sulfate

• 
  API

  Protirelin

• 
  ADC

  Rapamycin

• 
  API

  Retatrutide

  CAS:2381089-83-2

  Status:R&D

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Rusfertide

  CAS:1628323-80-7

  Status:R&D

  Indications:Diseases of blood and hematopoietic organs
• 
  API

  Semaglutide (Chemical synthesis)

  CAS:910463-68-2

  Status:DMF, WC

  Indications:Endocrine, nutritional, and metabolic disease
• 
  API

  Semaglutide (Semi-Recombinant)

  CAS:910463-68-2

  Status:DMF, WC

  Indications:Endocrine, nutritional, and metabolic diseases
• 
  API

  Semaglutide(for Injectable)

  CAS:910463-68-2